Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes-Reference-Cited by-同舟云学术

Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes

Published:2014-08 Issue:4 Volume:87 Page:234-240
ISSN:0195-6701
Container-title:Journal of Hospital Infection
language:en
Short-container-title:Journal of Hospital Infection

Author:

Lucena A.,Dalla Costa L.M.,Nogueira K.S.,Matos A.P.,Gales A.C.,Paganini M.C.,Castro M.E.S.,Raboni S.M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference34 articles.

1. Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000);Jones;Diagn Microbiol Infect Dis,2002

2. Metallo-β-lactamases: the quiet before the storm?;Walsh;Clin Microb Rev,2005

3. Molecular evolution of metallo-β-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity;Lagatolla;J Clin Microbiol,2006

4. Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates;Pitout;J Clin Microbiol,2007

5. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals;Gutiérrez;Antimicrob Agents Chemother,2007

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metallo-β-lactamases producing Pseudomonas aeruginosa and the molecular mechanism of drug resistance variants;Journal of King Saud University - Science;2024-10

2. A Review: Hospital Acquired Infection in Some Gram Negative Pathogenic Bacterial Strains;Journal of Contemporary Medical Sciences;2024-02-26

3. The Prevalence of Metallo-Beta-Lactamese-(MβL)-Producing Pseudomonas aeruginosa Isolates in Brazil: A Systematic Review and Meta-Analysis;Microorganisms;2023-09-21

4. Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing Pseudomonas aeruginosa;Annals of Laboratory Medicine;2023-09-04

5. Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa;Emerging Microbes & Infections;2023-03